Have a feature idea you'd love to see implemented?
Let us know!
REVB Revelation Biosciences Inc
Price (delayed)
$0.753
Market cap
$3.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$21.86
Enterprise value
-$3.31M
Highlights
The net income is up by 2.4% QoQ
REVB's equity has surged by 134% since the previous quarter but it has dropped by 70% year-on-year
The EPS has dropped by 105% year-on-year but it rose by 29% since the previous quarter
Key stats
What are the main financial stats of REVB
Market
Valuations
Earnings
Shares outstanding
4.29M
Market cap
$3.23M
Enterprise value
-$3.31M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$15.52M
EBITDA
-$15.49M
Free cash flow
-$16.61M
Per share
Balance sheet
Liquidity
EPS
-$21.86
Free cash flow per share
-$6.2
Book value per share
$1.63
Revenue per share
$0
TBVPS
$2.52
Total assets
$6.74M
Total liabilities
$4.07M
Debt
$0
Equity
$2.67M
Working capital
$2.59M
Debt to equity
0
Current ratio
1.64
Quick ratio
1.61
Net debt/EBITDA
0.42
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-135.1%
Return on equity
-311.3%
Return on invested capital
N/A
Return on capital employed
-580.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
REVB stock price
How has the Revelation Biosciences stock price performed over time
Intraday
-0.76%
1 week
-9.99%
1 month
-16.65%
1 year
-96.08%
YTD
-94.99%
QTD
-11.6%
Financial performance
How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.55M
Net income
-$15.52M
Gross margin
N/A
Net margin
N/A
REVB's operating income is down by 13% YoY but it is up by 10% from the previous quarter
The net income is up by 2.4% QoQ
Growth
What is Revelation Biosciences's growth rate over time
Valuation
What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
0.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 105% year-on-year but it rose by 29% since the previous quarter
REVB's equity has surged by 134% since the previous quarter but it has dropped by 70% year-on-year
The price to book (P/B) is 54% lower than the last 4 quarters average of 1.0
Efficiency
How efficient is Revelation Biosciences business performance
REVB's return on equity is down by 28% since the previous quarter
The company's return on assets fell by 13% QoQ
Dividends
What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for REVB.
Financial health
How did Revelation Biosciences financials performed over time
The company's total assets is 66% higher than its total liabilities
Revelation Biosciences's total liabilities has plunged by 63% from the previous quarter and by 25% YoY
The company's total assets has shrunk by 53% YoY and by 45% QoQ
The debt is 100% less than the equity
REVB's equity has surged by 134% since the previous quarter but it has dropped by 70% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.